常州市存仁生物工程有限公司

TH-302

TH-302

 Description of:TH-302
TH-302 is a selectively targeting hypoxic regions of solid tumors hypoxia-activated prodrug. Theoretical analysis:T...
更多>>
TAK-700 (Orteronel)

TAK-700 (Orteronel)

 Description of:TAK-700 (Orteronel)
orteronel(TAK-700) is currently in phase III clinical trials for the treatment of castration-resistant prost...
更多>>
Avasimibe(CI-1011)

Avasimibe(CI-1011)

 Description of:Avasimibe(CI-1011)
Avasimibe (CI-1011) is an orally bioavailable Acyl-CoA:Cholesterol O-Acyltransferase (ACAT) inhibitor. T...
更多>>
總數(shù): 3 頁: 1 / 1 首頁 ←上一頁 下一頁→ 末頁